A detailed history of Amalgamated Bank transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Amalgamated Bank holds 5,349 shares of LGND stock, worth $656,322. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,349
Previous 5,158 3.7%
Holding current value
$656,322
Previous $435,000 22.99%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$82.7 - $110.11 $15,795 - $21,031
191 Added 3.7%
5,349 $535,000
Q2 2024

Aug 12, 2024

SELL
$68.53 - $87.91 $10,142 - $13,010
-148 Reduced 2.79%
5,158 $435,000
Q1 2024

Apr 23, 2024

SELL
$68.64 - $89.2 $67,816 - $88,129
-988 Reduced 15.7%
5,306 $388,000
Q4 2023

Feb 06, 2024

SELL
$49.57 - $72.63 $7,683 - $11,257
-155 Reduced 2.4%
6,294 $450,000
Q3 2023

Nov 08, 2023

SELL
$58.86 - $72.67 $14,185 - $17,513
-241 Reduced 3.6%
6,449 $386,000
Q2 2023

Aug 11, 2023

BUY
$69.53 - $79.33 $834 - $951
12 Added 0.18%
6,690 $482,000
Q1 2023

May 02, 2023

SELL
$65.67 - $77.08 $34,279 - $40,235
-522 Reduced 7.25%
6,678 $491,000
Q3 2022

Nov 09, 2022

SELL
$0.01 - $107.56 $2 - $23,232
-216 Reduced 2.91%
7,200 $620,000
Q2 2022

Aug 15, 2022

BUY
$74.52 - $117.06 $3,427 - $5,384
46 Added 0.62%
7,416 $662,000
Q1 2022

Jun 30, 2022

SELL
$94.99 - $151.56 $36,761 - $58,653
-387 Reduced 4.99%
7,370 $829,000
Q4 2021

Feb 15, 2022

SELL
$127.69 - $165.85 $17,365 - $22,555
-136 Reduced 1.72%
7,757 $1.2 Million
Q3 2021

Oct 29, 2021

SELL
$102.33 - $144.73 $433,674 - $613,365
-4,238 Reduced 34.94%
7,893 $1.1 Million
Q2 2021

Aug 16, 2021

BUY
$113.03 - $155.64 $1.12 Million - $1.55 Million
9,937 Added 452.92%
12,131 $1.59 Million
Q1 2021

May 13, 2021

SELL
$99.52 - $215.83 $20,003 - $43,381
-201 Reduced 8.39%
2,194 $334,000
Q4 2020

Feb 12, 2021

BUY
$80.55 - $106.05 $1,933 - $2,545
24 Added 1.01%
2,395 $238,000
Q3 2020

Oct 30, 2020

SELL
$89.56 - $126.72 $6,985 - $9,884
-78 Reduced 3.18%
2,371 $226,000
Q2 2020

Aug 10, 2020

SELL
$68.28 - $123.65 $27,585 - $49,954
-404 Reduced 14.16%
2,449 $274,000
Q1 2020

May 13, 2020

SELL
$63.37 - $107.88 $5,576 - $9,493
-88 Reduced 2.99%
2,853 $207,000
Q4 2019

Feb 13, 2020

SELL
$96.94 - $113.59 $11,923 - $13,971
-123 Reduced 4.01%
2,941 $307,000
Q3 2019

Nov 13, 2019

SELL
$86.25 - $120.16 $5,088 - $7,089
-59 Reduced 1.89%
3,064 $305,000
Q2 2019

Aug 14, 2019

SELL
$107.38 - $129.34 $27,704 - $33,369
-258 Reduced 7.63%
3,123 $356,000
Q1 2019

May 15, 2019

BUY
$105.93 - $142.47 $11,122 - $14,959
105 Added 3.21%
3,381 $425,000
Q4 2018

Feb 15, 2019

BUY
$128.36 - $272.13 $234,513 - $497,181
1,827 Added 126.09%
3,276 $445,000
Q3 2018

Nov 14, 2018

SELL
$211.18 - $274.49 $415,602 - $540,196
-1,968 Reduced 57.59%
1,449 $398,000
Q2 2018

Jul 18, 2018

BUY
$150.77 - $207.98 $69,052 - $95,254
458 Added 15.48%
3,417 $708,000
Q1 2018

May 22, 2018

SELL
$138.63 - $182.62 $6,792 - $8,948
-49 Reduced 1.63%
2,959 $489,000
Q4 2017

Feb 13, 2018

BUY
$128.36 - $147.04 $23,874 - $27,349
186 Added 6.59%
3,008 $412,000
Q3 2017

Nov 09, 2017

BUY
$120.91 - $137.94 $341,208 - $389,266
2,822
2,822 $384,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.07B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.